Analyst Ratings For Neon Therapeutics Inc (NASDAQ:NTGN)
Today, Bank of America initiated coverage on Neon Therapeutics Inc (NASDAQ:NTGN) with a Buy.
There are 0 sell ratings, 0 hold ratings, 1 buy ratings, 0 strong buy ratings on the stock.
The current consensus rating on Neon Therapeutics Inc (NASDAQ:NTGN) is Buy with a consensus target price of N/A per share, a potential N/A.
Some recent analyst ratings include
- 7/23/2018-Bank of America initiated coverage with a Buy rating.
Recent Trading Activity for Neon Therapeutics Inc (NASDAQ:NTGN)
Shares of Neon Therapeutics Inc closed the previous trading session at 10,82 −0,18 1,64 % with shares trading hands.